Clinical trial
Cetuximab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients…
NCT00081302 · Radiation Therapy Oncology Group, Other · Completed
Key facts
| NCT number | NCT00081302 |
|---|---|
| Title | Cetuximab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Unresectable Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer |
| Official title | A Phase II Study Of Cetuximab (C225) In Combination With Chemoradiation In Patients With Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC) |
| Lead sponsor | Radiation Therapy Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Biological, Drug, Radiation |
| Interventions | cetuximab, carboplatin, paclitaxel, radiation therapy |
| Start date | Mar 1, 2004 |
| Primary completion | Dec 1, 2005 |
| Completion | Nov 1, 2013 |
| First posted | Apr 8, 2004 |
| Last update posted | Nov 17, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: